GridAI Technologies Corp. (GRDX)
NCM · Healthcare · Biotechnology
$5.27
-10.68%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$35.1M
Shares Outstanding
6.7M
P/S (TTM)
472x
Exchange
NCM
Currency
USD
About GridAI Technologies Corp.
GridAI Technologies Corp., together with its subsidiaries, designs and develops an artificial intelligence (AI)-driven software and device platform that enables utilities, retailers, and large power users to manage load and distributed energy resources. It also develops Adrulipase, a recombinant lipase enzyme program for the treatment of exocrine pancreatic insufficiency. The company is based in Edinburgh, United Kingdom.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 36K | 38K |
| Gross Profit | -614K | |||
| Operating Income | -639K | -935K | -4.7M | -3.6M |
| Net Income | -998K | -1.2M | -3.0M | -3.6M |
| Diluted EPS | $-0.63 | $-0.75 | $nan | $-0.82 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 36K |
| Gross Profit | 0.00 | -657K | ||
| Operating Income | -12.7M | -15.8M | -15.6M | -7.1M |
| Net Income | -14.6M | -15.8M | -18.1M | -6.4M |
| Diluted EPS | $-1,250.82 | $-143.64 | $-15.99 | $-4.16 |